Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02655016
Title A Study of Niraparib Maintenance Treatment in Patients With HRD-Positive Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Tesaro, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA | GBR | FRA | ESP | DEU | CAN | BEL

Facility Status City State Zip Country Details
GSK Investigational Site Mesa Arizona 85284 United States Details
GSK Investigational Site Tucson Arizona 85710 United States Details
GSK Investigational Site Tucson Arizona 85724 United States Details
GSK Investigational Site Los Angeles California 90095 United States Details
GSK Investigational Site San Francisco California 94115 United States Details
GSK Investigational Site San Francisco California 94118 United States Details
GSK Investigational Site Santa Rosa California 95403 United States Details
GSK Investigational Site Hartford Connecticut 06102 United States Details
GSK Investigational Site New Haven Connecticut 06510 United States Details
GSK Investigational Site Hollywood Florida 33323 United States Details
GSK Investigational Site Jacksonville Florida 32224 United States Details
GSK Investigational Site Miami Florida 33136 United States Details
GSK Investigational Site Atlanta Georgia 30342 United States Details
GSK Investigational Site Augusta Georgia 30912 United States Details
GSK Investigational Site Savannah Georgia 31404 United States Details
GSK Investigational Site Chicago Illinois 60612 United States Details
GSK Investigational Site Hinsdale Illinois 60521 United States Details
GSK Investigational Site Warrenville Illinois 60555 United States Details
GSK Investigational Site Indianapolis Indiana 46237 United States Details
GSK Investigational Site Indianapolis Indiana 46260 United States Details
GSK Investigational Site Iowa City Iowa 52242-1009 United States Details
GSK Investigational Site Baton Rouge Louisiana 70817 United States Details
GSK Investigational Site Covington Louisiana 70433 United States Details
GSK Investigational Site New Orleans Louisiana 70121 United States Details
GSK Investigational Site Baltimore Maryland 21215-5271 United States Details
GSK Investigational Site Silver Spring Maryland 20910 United States Details
GSK Investigational Site Burlington Massachusetts 01805 United States Details
GSK Investigational Site Springfield Massachusetts 01199 United States Details
GSK Investigational Site Grand Rapids Michigan 49503 United States Details
GSK Investigational Site Minneapolis Minnesota 55404 United States Details
GSK Investigational Site Springfield Missouri 65807 United States Details
GSK Investigational Site Middletown New Jersey 07748 United States Details
GSK Investigational Site Neptune New Jersey 07753 United States Details
GSK Investigational Site Teaneck New Jersey 07666 United States Details
GSK Investigational Site Buffalo New York 14263 United States Details
GSK Investigational Site Harrison New York 10604 United States Details
GSK Investigational Site Mineola New York 11501 United States Details
GSK Investigational Site New York New York 10016 United States Details
GSK Investigational Site New York New York 10065 United States Details
GSK Investigational Site Rochester New York 14620 United States Details
GSK Investigational Site Chapel Hill North Carolina 27599-7570 United States Details
GSK Investigational Site Wilmington North Carolina 28401 United States Details
GSK Investigational Site Cleveland Ohio 44111 United States Details
GSK Investigational Site Cleveland Ohio 44124 United States Details
GSK Investigational Site Columbus Ohio 43210 United States Details
GSK Investigational Site Mayfield Heights Ohio 44124 United States Details
GSK Investigational Site Oklahoma City Oklahoma 73104 United States Details
GSK Investigational Site Tulsa Oklahoma 74146 United States Details
GSK Investigational Site Portland Oregon 97210 United States Details
GSK Investigational Site Springfield Oregon 97477 United States Details
GSK Investigational Site Philadelphia Pennsylvania 19104 United States Details
GSK Investigational Site Willow Grove Pennsylvania 19090 United States Details
GSK Investigational Site Providence Rhode Island 02905 United States Details
GSK Investigational Site Charleston South Carolina 29425 United States Details
GSK Investigational Site Sioux Falls South Dakota 57105 United States Details
GSK Investigational Site Austin Texas 78731 United States Details
GSK Investigational Site Fort Worth Texas 76104 United States Details
GSK Investigational Site San Antonio Texas 78229 United States Details
GSK Investigational Site The Woodlands Texas 77380 United States Details
GSK Investigational Site Tyler Texas 75701 United States Details
GSK Investigational Site Salt Lake City Utah 84112 United States Details
GSK Investigational Site Kennewick Washington 99336 United States Details
GSK Investigational Site Seattle Washington 98104 United States Details
GSK Investigational Site Spokane Washington 99202 United States Details
GSK Investigational Site Morgantown West Virginia 26505 United States Details
GSK Investigational Site Milwaukee Wisconsin 53226 United States Details
GSK Investigational Site Bonheiden 2820 Belgium Details
GSK Investigational Site Bruxelles 1000 Belgium Details
GSK Investigational Site Bruxelles 1200 Belgium Details
GSK Investigational Site Charleroi 6000 Belgium Details
GSK Investigational Site Gent 9000 Belgium Details
GSK Investigational Site Hasselt 3500 Belgium Details
GSK Investigational Site Leuven 3000 Belgium Details
GSK Investigational Site Libramont 6800 Belgium Details
GSK Investigational Site Namur 5000 Belgium Details
GSK Investigational Site Sint-Niklaas 9100 Belgium Details
GSK Investigational Site Calgary Alberta T2N 4N2 Canada Details
GSK Investigational Site Kelowna British Columbia V1Y 5L3 Canada Details
GSK Investigational Site Surrey British Columbia V3V 1Z2 Canada Details
GSK Investigational Site Vancouver British Columbia V5Z 4E6 Canada Details
GSK Investigational Site Barrie Ontario L4M 6M2 Canada Details
GSK Investigational Site London Ontario N6A 4L6 Canada Details
GSK Investigational Site Ottawa Ontario K1Y 4E9 Canada Details
GSK Investigational Site Toronto Ontario M4N 3M5 Canada Details
GSK Investigational Site Toronto Ontario M5G 1X6 Canada Details
GSK Investigational Site Montreal Quebec H3T 1E2 Canada Details
GSK Investigational Site Montreal Quebec H4A 3J1 Canada Details
GSK Investigational Site Montréal Quebec H2X 0A9 Canada Details
GSK Investigational Site Brno 602 00 Czechia Details
GSK Investigational Site Ostrava 708 52 Czechia Details
GSK Investigational Site Plzen-Lochotin 30460 Czechia Details
GSK Investigational Site Prague 10034 Czechia Details
GSK Investigational Site Prague 128 51 Czechia Details
GSK Investigational Site Aalborg 9000 Denmark Details
GSK Investigational Site Herlev 2730 Denmark Details
GSK Investigational Site Koebenhavn Oe 2100 Denmark Details
GSK Investigational Site Odense 5000 Denmark Details
GSK Investigational Site Kuopio 70210 Finland Details
GSK Investigational Site Oulu 90029 Finland Details
GSK Investigational Site Tampere 33521 Finland Details
GSK Investigational Site Turku 20520 Finland Details
GSK Investigational Site Angers 49000 France Details
GSK Investigational Site Caen Cedex 05 14076 France Details
GSK Investigational Site Montpellier Cedex 5 34298 France Details
GSK Investigational Site Nice Cedex 2 06189 France Details
GSK Investigational Site Paris 75020 France Details
GSK Investigational Site Pierre-Benite cedex 69495 France Details
GSK Investigational Site Rennes Cedex 35042 France Details
GSK Investigational Site Saint-Herblain 44805 France Details
GSK Investigational Site Heidelberg Baden-Wuerttemberg 69120 Germany Details
GSK Investigational Site Mannheim Baden-Wuerttemberg 68167 Germany Details
GSK Investigational Site Fuerth Bayern 90766 Germany Details
GSK Investigational Site Muenchen Bayern 81377 Germany Details
GSK Investigational Site Muenchen Bayern 81737 Germany Details
GSK Investigational Site Goettingen Niedersachsen 37075 Germany Details
GSK Investigational Site Essen Nordrhein-Westfalen 45136 Germany Details
GSK Investigational Site Ludwigshafen Rheinland-Pfalz 67063 Germany Details
GSK Investigational Site Dresden Sachsen 01307 Germany Details
GSK Investigational Site Berlin 13353 Germany Details
GSK Investigational Site Hamburg 20246 Germany Details
GSK Investigational Site Debrecen 4032 Hungary Details
GSK Investigational Site Gyor 9024 Hungary Details
GSK Investigational Site Dublin 8 Ireland Details
GSK Investigational Site Galway H91 YR71 Ireland Details
GSK Investigational Site Waterford Ireland Details
GSK Investigational Site Beer Sheva 84101 Israel Details
GSK Investigational Site Haifa 3109601 Israel Details
GSK Investigational Site Haifa 38100 Israel Details
GSK Investigational Site Holon 58100 Israel Details
GSK Investigational Site Petach Tikva 49100 Israel Details
GSK Investigational Site Tel Aviv 64239 Israel Details
GSK Investigational Site Tel Hashomer 52621 Israel Details
GSK Investigational Site Napoli Campania 80131 Italy Details
GSK Investigational Site Modena Emilia-Romagna 41100 Italy Details
GSK Investigational Site Milano Lombardia 20132 Italy Details
GSK Investigational Site Milano Lombardia 20133 Italy Details
GSK Investigational Site Candiolo (TO) Piemonte 10060 Italy Details
GSK Investigational Site Lecce Puglia 73100 Italy Details
GSK Investigational Site Mirano Veneto 30035 Italy Details
GSK Investigational Site Oslo 0310 Norway Details
GSK Investigational Site Lodz 93-513 Poland Details
GSK Investigational Site Lublin 20-090 Poland Details
GSK Investigational Site Olsztyn 10-561 Poland Details
GSK Investigational Site Poznan 60-569 Poland Details
GSK Investigational Site Arkhangelsk 163045 Russian Federation Details
GSK Investigational Site Chelyabinsk 454048 Russian Federation Details
GSK Investigational Site Irkutsk 664035 Russian Federation Details
GSK Investigational Site Ivanovo 153040 Russian Federation Details
GSK Investigational Site Kazan 420029 Russian Federation Details
GSK Investigational Site Krasnoyarsk 660133 Russian Federation Details
GSK Investigational Site Orenburg 460021 Russian Federation Details
GSK Investigational Site Pyatigorsk 357502 Russian Federation Details
GSK Investigational Site Saint-Petersburg 197758 Russian Federation Details
GSK Investigational Site Samara 443011 Russian Federation Details
GSK Investigational Site St-Petersburg 194017 Russian Federation Details
GSK Investigational Site St. Petersburg 191104 Russian Federation Details
GSK Investigational Site St. Petersburg 197758 Russian Federation Details
GSK Investigational Site Badalona 08916 Spain Details
GSK Investigational Site Barcelona 08003 Spain Details
GSK Investigational Site Barcelona 08036 Spain Details
GSK Investigational Site Barcelona 8035 Spain Details
GSK Investigational Site Cordoba 14004 Spain Details
GSK Investigational Site Elche 03203 Spain Details
GSK Investigational Site Girona 17007 Spain Details
GSK Investigational Site Hospitalet de Llobregat, Barcelona 08907 Spain Details
GSK Investigational Site Madrid 28033 Spain Details
GSK Investigational Site Madrid 28034 Spain Details
GSK Investigational Site Madrid 28041 Spain Details
GSK Investigational Site Madrid 28046 Spain Details
GSK Investigational Site San Sebastián 20014 Spain Details
GSK Investigational Site Sevilla 41013 Spain Details
GSK Investigational Site Sevilla 41014 Spain Details
GSK Investigational Site Valencia 46009 Spain Details
GSK Investigational Site Valencia 46010 Spain Details
GSK Investigational Site Zaragoza 50009 Spain Details
GSK Investigational Site Stockholm SE-171 76 Sweden Details
GSK Investigational Site Uppsala SE-751 85 Sweden Details
GSK Investigational Site Basel 4031 Switzerland Details
GSK Investigational Site Bern 3010 Switzerland Details
GSK Investigational Site Frauenfeld 8501 Switzerland Details
GSK Investigational Site Zurich 8091 Switzerland Details
GSK Investigational Site Dnipropetrovsk 49102 Ukraine Details
GSK Investigational Site Dnipro 49100 Ukraine Details
GSK Investigational Site Ivano-Frankivsk 76000 Ukraine Details
GSK Investigational Site Kharkiv 61070 Ukraine Details
GSK Investigational Site Kherson 73000 Ukraine Details
GSK Investigational Site Krivoy Rog 50048 Ukraine Details
GSK Investigational Site Kyiv 03022 Ukraine Details
GSK Investigational Site Vinnitsia 21029 Ukraine Details
GSK Investigational Site Zaporizhzhia 69040 Ukraine Details
GSK Investigational Site Portsmouth Hampshire PO6 3LY United Kingdom Details
GSK Investigational Site Bath Somerset BA1 3NG United Kingdom Details
GSK Investigational Site Stoke-on-Trent Staffordshire ST4 6QG United Kingdom Details
GSK Investigational Site Blackburn BB2 3HH United Kingdom Details
GSK Investigational Site Exeter EX2 5DW United Kingdom Details
GSK Investigational Site Glasgow G12 0YN United Kingdom Details
GSK Investigational Site London W12 0HS United Kingdom Details
GSK Investigational Site Sheffield S10 2SJ United Kingdom Details
GSK Investigational Site Truro TR1 3LJ United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field